Skip to content

Clinical trials

Completed Alzheimer Disease trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Israel Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20071
20083
20093
20103
20111
20131
20143
20161
20191
20201
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S3
Eli Lilly and Company2
Neuronix Ltd2
Novartis Pharmaceuticals2
Abarbanel Mental Health Center1
Assaf-Harofeh Medical Center1
Beersheva Mental Health Center1
Brainsway1
Eidos Therapeutics, a BridgeBio company1
Eli Sprecher, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease25
Dementia6
Cognitive Dysfunction3
Sleep Wake Disorders3
Amyloidosis2
Heart Diseases2
Stroke2
Amyloid Neuropathies, Familial1
Atrial Fibrillation1
Brain Diseases1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.